Genetic counseling and testing for breast-ovarian cancer susceptibility: What do women want?

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 133-138

  Audrain, Janet ^a   Rimer, Barbara ^a   Cella, David ^a   Garber, Judy ^a   Peshkin, Beth N ^a   Ellis, Judith ^a   Schildkraut, Joellen ^a   Stefanek, Michael ^a   Vogel, Victor ^a   Lerman, Caryn ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; HIGH RISK POPULATION; HUMAN; NORMAL HUMAN; OVARY CANCER; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL;

EID: 0031962092     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.133     Document Type: Article

References (27)

1. Struewing JP, Lerman C, Kase RG, et al: Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4:169-173, 1995
2. Chaliki H, Loader S, Levenkron JC, et al: Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 85:1133-1135, 1995
3. Lerman C, Daly M, Masny A, et al: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843-850, 1994
4. Andrykowski MA, Munn RK, Studts JL: Interest in learning of personal genetic risk for cancer: A general population survey. Prev Med 25:527-536, 1996
5. Tambor ES, Rimer BK, Strigo TS: Genetic testing for breast cancer susceptibility: Awareness and interest among women in the general population. Am J Med Genet 68:43-49, 1997
6. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14:1730-1736, 1996
7. Li FP, Fraumeni JF Jr: Predictive testing for inherited mutations in cancer-susceptibility genes. J Clin Oncol 10:1203-1204, 1992 (editorial)
8. Botkin JR, Croyle RT, Smith KR, et al: A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J Natl Cancer Inst 88:872-882, 1996
9. Lerman C, Biesecker B, Benkendorf JL, et al: Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89:148-157, 1997
10. Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. JAMA 277:997-1003, 1997
11. Task Force on Genetic Testing: Interim Principles of the Task Force on Genetic Testing of the NIH-DOE Working Group on Ethical, Legal, and Social Implications of Human Genome Research. Washington, DC, Department of Health and Human Services, March 1996
12. Graham J, Peshkin B, Isaacs C, et al: Basic knowledge deficit about heritable cancers among health care providers: Results of a survey. Proc Am Soc Clin Oncol 15:334, 1996 (abstr)
13. Giardiello FM, Brensinger JD, Petersen GM, et al: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 336:823-827, 1997
14. Rimer BK, Schildkraut JM, Lerman C, et al: Participation in a women's breast cancer risk counseling trial: Who participates? Who declines? Cancer 77:2348-2355, 1996
15. Schwartz MD, Lerman C, Audrain J, et al: The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Ann Behav Med (in press)
16. Hoffman KJ, Tambor ES, Chase GA, et al: Physicians' knowledge of genetics and genetic tests. Acad Med 68:625-632, 1993
17. Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. JAMA 273:577-585, 1995
18. American Society of Human Genetics: Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 55:ii-iv, 1994
19. National Center for Human Genome Research: Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 271:785, 1994
20. Emanuel EJ, Emanuel LL: Four models of the physician-patient relationship. JAMA 267:2221-2226, 1992 (see comment citations in Medicine)
21. Kessler S: Genetic Counseling: Psychological Dimensions. New York, NY, Academic, 1979
22. Lerman C, Schwartz MD, Lin TH, et al: The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 65:414-420, 1997
23. Lerman C, Narod S, Schulman K, et al: BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision-making and outcomes. JAMA 275:1885-1892, 1996
24. Hughes C, Gomez-Caminero A, Benkendorf J, et al: Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Education Counsel 32:51-62, 1997
25. Offit K, Brown K: Quantitating familial cancer risk: A resource for clinical oncologists. J Clin Oncol 8:1724-1736, 1994
26. Clayton EW, Hannig VL, Pfotenhauer JP, et al: Teaching about cystic fibrosis carrier screening by using written and video information. Am J Hum Genet 57:171-181, 1995
27. Magyari T, Smith ACM, Wholey K: Effectiveness of multimedia decision-support materials vs. traditional genetic counseling for CF carrier screening. Am J Hum Genet 55:A21, 1994 (suppl; abstr)